Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 9/20 | 0.61 |
| ▸ | ADAMTS4 | O75173 | 3/20 | 0.61 |
| ▸ | MMP13 | P45452 | 3/20 | 0.61 |
| ▸ | MMP8 | P22894 | 1/20 | 0.61 |
| ▸ | MMP2 | P08253 | 11/20 | 0.59 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.53 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL698080 | 1.00 | MMP9 (0.61) | MMP9ADAMTS4MMP13MMP8MMP2 | |
| SCHEMBL713304 | 1.00 | MMP9 (0.61) | MMP9ADAMTS4MMP13MMP8MMP2 | |
| SCHEMBL8492008 | 0.92 | MMP9 (0.74) | MMP9ADAMTS4MMP13MMP8MMP2 | |
| SCHEMBL8485346 | 0.92 | MMP9 (0.74) | MMP9ADAMTS4MMP13MMP8MMP2 | |
| SCHEMBL5191062 | 0.87 | MMP2 (0.63) | MMP9ADAMTS4MMP13MMP8MMP2 | |
| SCHEMBL8685172 | 0.87 | MMP2 (0.63) | MMP9ADAMTS4MMP13MMP8MMP2 | |
| SCHEMBL5178707 | 0.85 | ADAMTS4 (0.52) | MMP9ADAMTS4MMP13MMP8MMP2 | |
| SCHEMBL2219245 | 0.85 | MMP2 (0.56) | MMP9ADAMTS4MMP13MMP8MMP2 | |
| SCHEMBL698843 | 0.85 | TDP1 (0.63) | MMP9ADAMTS4MMP13MMP8MMP2 | |
| SCHEMBL7099492 | 0.85 | MMP2 (0.63) | MMP9ADAMTS4MMP13MMP8MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11440882-B2 | Process for the preparation of dexmethyl phenidate hydrochloride | HARMAN FINOCHEM LIMITED (IN) | 2022-09-13 | — | — | US | claimed |
| US-20210371381-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF DEXMETHYL PHENIDATE HYDROCHLORIDE | HARMAN FINOCHEM LIMITED (IN) | 2021-12-02 | — | — | US | claimed |
| EP-3484850-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF DEXMETHYL PHENIDATE HYDROCHLORIDE | Harman Finochem Limited (IN) | 2019-05-22 | — | — | EP | claimed |
| WO-2018015971-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF DEXMETHYL PHENIDATE HYDROCHLORIDE | HARMAN FINOCHEM LIMITED (IN) | 2018-01-25 | — | — | WO | claimed |
| WO-2010010359-A2 | A PROCESS FOR THE PREPARATION OF CINACALCET AND ITS SALTS | CILPA LIMITED (IN) | 2010-01-28 | — | — | WO | claimed |
| EP-1457487-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE CIS-PIPERIDINE DERIVATIVES | Toray Fine Chemicals Co., Ltd. (JP) | 2004-09-15 | — | — | EP | claimed |
| US-20040171836-A1 | Method for producing optical-active cis-piperidine derivatives | TORAY FINE CHEMICALS CO., LTD., A CORPORATION OF JAPAN, (JP) | 2004-09-02 | — | — | US | claimed |
| JP-4018057-A | — | — | None | — | — | JP | disclosed |
| US-11440882-B2 | Process for the preparation of dexmethyl phenidate hydrochloride | HARMAN FINOCHEM LIMITED (IN) | 2022-09-13 | — | — | US | disclosed |
| US-20210371381-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF DEXMETHYL PHENIDATE HYDROCHLORIDE | HARMAN FINOCHEM LIMITED (IN) | 2021-12-02 | — | — | US | disclosed |
| EP-3484850-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF DEXMETHYL PHENIDATE HYDROCHLORIDE | Harman Finochem Limited (IN) | 2019-05-22 | — | — | EP | disclosed |
| WO-2018015971-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF DEXMETHYL PHENIDATE HYDROCHLORIDE | HARMAN FINOCHEM LIMITED (IN) | 2018-01-25 | — | — | WO | disclosed |
| EP-2423211-B1 | PROCESSES FOR PRODUCING (1S,6S)- OR (1R,6R)-CIS-2,8-DIAZABICYCLO[4.3.0]NONANE AND INTERMEDIATE THEREOF | KANEKA CORP (JP) | 2014-04-16 | — | — | EP | disclosed |
| US-20040171836-A1 | Method for producing optical-active cis-piperidine derivatives | TORAY FINE CHEMICALS CO., LTD., A CORPORATION OF JAPAN, (JP) | 2004-09-02 | — | — | US | disclosed |
| EP-0906906-B1 | PROCESS FOR PREPARING OPTICALLY ACTIVE 2-PIPERAZINECARBOXYLIC ACID DERIVATIVES | TORAY INDUSTRIES (JP) | 2003-08-27 | — | — | EP | disclosed |
| US-5952503-A | Method for producing optically-active 2-piperazinecarboxylic acid derivatives | TORAY INDUSTRIES, INC. (JP) | 1999-09-14 | — | — | US | disclosed |
| EP-0906906-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE 2-PIPERAZINECARBOXYLIC ACID DERIVATIVES | TORAY INDUSTRIES, INC. (JP) | 1999-04-07 | — | — | EP | disclosed |
| JP-H0418057-A | PRODUCTION OF OPTICALLY ACTIVE 1,2-PROPANEDIAMINE | TORAY IND INC | 1992-01-22 | — | — | JP | disclosed |
| US-4610827-A | Amino acid complex and a method for optical resolution of a DL-amino acid | AJINOMOTO CO., INC. (JP) | 1986-09-09 | — | — | US | disclosed |
| EP-0132373-A1 | A neutral amino acid complex and a method for optical resolution of a DL-amino acid | AJINOMOTO CO., INC. (JP) | 1985-01-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171836-A1 | Method for producing optical-active cis-piperidine derivatives | TYR, DDC, TARBP1 | MMP9 1373/4885ADAMTS4 2548/4885MMP13 1152/4885 |
| US-11440882-B2 | Process for the preparation of dexmethyl phenidate hydrochloride | SLC6A3, COMT, DAO | MMP9 1184/4885ADAMTS4 1742/4885MMP13 2004/4885 |
| US-20210371381-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF DEXMETHYL PHENIDATE HYDROCHLORIDE | COMT, SLC6A3, DAO | MMP9 1477/4885ADAMTS4 1495/4885MMP13 2105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.